The murine stanniocalcin 2 gene is a negative regulator of postnatal growth

Endocrinology

Volumn 149, Issue 5, 2008, Pages 2403-2410

  Chang, Andy C M ^a,b   Hook, Jeff ^a   Lemckert, Frances A ^a   McDonald, Michelle M ^a   Nguyen, Mai Anh T ^a   Hardeman, Edna C ^a,b   Little, David G ^a,b   Gunning, Peter W ^a,b   Reddel, Roger R ^a,b,c  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b University of Sydney   (Australia)

^c CHILDREN'S MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOCALCIN; STANNIOCALCIN 1; STANNIOCALCIN 2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; FEMALE; FERTILITY; GENE DELETION; MALE; MAMMARY GLAND; MOUSE; NONHUMAN; PHENOTYPE; PHOSPHATE BLOOD LEVEL; POSTNATAL GROWTH; PRIORITY JOURNAL; PROTEIN EXPRESSION; WEANING; WEIGHT GAIN;

ANIMALS; ANIMALS, NEWBORN; BODY WEIGHT; BONE DEVELOPMENT; CROSSES, GENETIC; FEMALE; GLYCOPROTEINS; GROWTH AND DEVELOPMENT; MALE; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MOTOR ACTIVITY; MUSCLE, SKELETAL; ORGAN SIZE; REPRODUCTION; SEX CHARACTERISTICS;

EID: 42449159796     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2007-1219     Document Type: Article

References (49)

1. Chang ACM, Janosi J, Hulsbeek M, De Jong D, Jeffrey KJ, Noble JR, Reddel RR 1995 A novel human cDNA highly homologous to the fish hormone stanniocalcin. Mol Cell Endocrinol 112:241-247
2. Olsen HS, Cepeda MA, Zhang QQ, Rosen CA, Vozzolo BL, Wagner GF 1996 Human stanniocalcin: A possible hormonal regulator of mineral metabolism. Proc Natl Acad Sci USA 93:1792-1796
3. Chang ACM, Dunham MA, Jeffrey KJ, Reddel RR 1996 Molecular cloning and characterization of mouse stanniocalcin cDNA. Mol Cell Endocrinol 124:185-187
4. Varghese R, Wong CK, Deol H, Wagner GF, DiMattia GE 1998 Comparative analysis of mammalian stanniocalcin genes. Endocrinology 139:4714-4725
5. Yoshiko Y, Son A, Maeda S, Igarashi A, Takano S, Hu J, Maeda N 1999 Evidence for stanniocalcin gene expression in mammalian bone. Endocrinology 140:1869-1874
6. Jiang WQ, Chang ACM, Satoh M, Furuichi Y, Tam PP, Reddel RR 2000 The distribution of stanniocalcin 1 protein in fetal mouse tissues suggests a role in bone and muscle development. J Endocrinol 165:457-466
7. Stasko SE, Wagner GF 2001 Possible roles for stanniocalcin during early skeletal patterning and joint formation in the mouse. J Endocrinol 171:237-248
8. Chang ACM, Jellinek DA, Reddel RR 2003 Mammalian stanniocalcins and cancer. Endocr Relat Cancer 10:359-373
9. Yoshiko Y, Aubin JE 2004 Stanniocalcin 1 as a pleiotropic factor in mammals. Peptides 25:1663-1669
10. Serlachius M, Zhang KZ, Andersson LC 2004 Stanniocalcin in terminally differentiated mammalian cells. Peptides 25:1657-1662
11. Wagner GF, DiMattia GE 2006 The stanniocalcin family of proteins. J Exp Zoolog A Comp Exp Biol 305:769-780
12. Chang ACM, Reddel RR 1998 Identification of a second stanniocalcin cDNA in mouse and human: stanniocalcin 2. Mol Cell Endocrinol 141:95-99
13. DiMattia GE, Varghese R, Wagner GF 1998 Molecular cloning and characterization of stanniocalcin-related protein. Mol Cell Endocrinol 146:137-140
14. Ishibashi K, Miyamoto K, Taketani Y, Morita K, Takeda E, Sasaki S, Imai I 1998 Molecular cloning of a second human stanniocalcin homologue (STC2). Biochem Biophys Res Commun 250:252-258
15. Jellinek DA, Chang AC, Larsen MR, Wang X, Robinson PJ, Reddel RR 2000 Stanniocalcin 1 and 2 are secreted as phosphoproteins from human fibrosarcoma cells. Biochem J 350:453-461
16. Moore EE, Kuestner RE, Conklin DC, Whitmore TE, Downey W, Buddle MM, Adams RL, Bell LA, Thompson DL, Wolf A, Chen L, Stamm MR, Grant FJ, Lok S, Ren H, De Jongh KS 1999 Stanniocalcin 2: characterization of the protein and its localization to human pancreatic α cells. Horm Metab Res 31:406-414
17. Wagner GF, Vozzolo BL, Jaworski E, Haddad M, Kline RL, Olsen HS, Rosen CA, Davidson MB, Renfro JL 1997 Human stanniocalcin inhibits renal phosphate excretion in the rat. J Bone Miner Res 12:165-171
18. Madsen KL, Tavernini MM, Yachimec C, Mendrick DL, Alfonso PJ, Buergin M, Olsen HS, Antonaccio MJ, Thomson AB, Fedorak RN 1998 Stanniocalcin: a novel protein regulating calcium and phosphate transport across mammalian intestine. Am J Physiol 274:G96-G102
19. Chakraborty A, Brooks HL, Zhang P, Smith W, McReynolds M, Hoying J, Bick RJ, Truong L, Poindexter B, Lan H, Elbjeirami W, Sheikh-Hamad D 2007 Stanniocalcin-1 regulates endothelial gene expression and modulates transendothelial migration of leukocytes. Am J Physiol Renal Physiol 292:F895-F904
20. Zhang K, Lindsberg PJ, Tatlisumak T, Kaste M, Olsen HS, Andersson LC 2000 Stanniocalcin: a molecular guard of neurons during cerebral ischemia. Proc Natl Acad Sci USA 97:3637-3642
21. Varghese R, Gagliardi AD, Bialek PE, Yee SP, Wagner GF, DiMattia GE 2002 Overexpression of human stanniocalcin affects growth and reproduction in transgenic mice. Endocrinology 143:868-876
22. Filvaroff EH, Guillet S, Zlot C, Bao M, Ingle G, Steinmetz H, Hoeffel J, Bunting S, Ross J, Carano RA, Powell-Braxton L, Wagner GF, Eckert R, Gerritsen ME, French DM 2002 Stanniocalcin 1 alters muscle and bone structure and function in transgenic mice. Endocrinology 143:3681-3690
23. Chang AC, Cha J, Koentgen F, Reddel RR 2005 The murine stanniocalcin 1 gene is not essential for growth and development. Mol Cell Biol 25:10604-10610
24. Iida K, Rosen CJ, Ackert-Bicknell C, Thorner MO 2005 Genetic differences in the IGF-I gene among inbred strains of mice with different serum IGF-I levels. J Endocrinol 186:481-489
25. Corbett MA, Robinson CS, Dunglison GF, Yang N, Joya JE, Stewart AW, Schnell C, Gunning PW, North KN, Hardeman EC 2001 A mutation in α-tropomyosin(slow) affects muscle strength, maturation and hypertrophy in a mouse model for nemaline myopathy. Hum Mol Genet 10:317-328
26. Yoshiko Y, Maeda N, Aubin JE 2003 Stanniocalcin 1 stimulates osteoblast differentiation in rat calvaria cell cultures. Endocrinology 144:4134-4143
27. Wu S, Yoshiko Y, De Luca F 2006 Stanniocalcin 1 acts as a paracrine regulator of growth plate chondrogenesis. J Biol Chem 281:5120-5127
28. Yoshiko Y, Candeliere GA, Maeda N, Aubin JE 2007 Osteoblast autonomous Pi regulation via Pit1 plays a role in bone mineralization. Mol Cell Biol 27:4465-4474
29. Gagliardi AD, Kuo EY, Raulic S, Wagner GF, DiMattia GE 2005 Human stanniocalcin-2 exhibits potent growth suppressive properties in transgenic mice independent of growth hormone and IGFs. Am J Physiol Endocrinol Metab 288:E92-E105
30. Norstedt G, Palmiter R 1984 Secretory rhythm of growth hormone regulates sexual differentiation of mouse liver. Cell 36:805-812
31. Wallenius K, Sjogren K, Peng XD, Park S, Wallenius V, Liu JL, Umaerus M, Wennbo H, Isaksson O, Frohman L, Kineman R, Ohlsson C, Jansson JO 2001 Liver-derived IGF-I regulates GH secretion at the pituitary level in mice. Endocrinology 142:4762-4770
32. Kaplan SA, Cohen P 2007 Review: the somatomedin hypothesis 2007: 50 years later. J Clin Endocrinol Metab 92:4529-4535
33. Yoshiko Y, Aubin JE, Maeda N 2002 Stanniocalcin 1 (STC1) protein and mRNA are developmentally regulated during embryonic mouse osteogenesis: the potential of stc1 as an autocrine/paracrine factor for osteoblast development and bone formation. J Histochem Cytochem 50:483-492
34. 3 of expression of stanniocalcin messages in the rat kidney and ovary. FEBS Lett 459:119-122
35. Stasko SE, DiMattia GE, Wagner GF 2001 Dynamic changes in stanniocalcin gene expression in the mouse uterus during early implantation. Mol Cell Endocrinol 174:145-149
36. Xiao LJ, Yuan JX, Song XX, Li YC, Hu ZY, Liu YX 2006 Expression and regulation of stanniocalcin 1 and 2 in rat uterus during embryo implantation and decidualization. Reproduction 131:1137-1149
37. Deol HK, Varghese R, Wagner GF, DiMattia GE 2000 Dynamic regulation of mouse ovarian stanniocalcin expression during gestation and lactation. Endocrinology 141:3412-3421
38. Welcsh PL, Lee MK, Gonzalez-Hernandez RM, Black DJ, Mahadevappa M, Swisher EM, Warrington JA, King MC 2002 BRCA1 transcriptionally regulates genes involved in breast tumorigenesis. Proc Natl Acad Sci USA 99:7560-7565
39. Hasilo CP, McCudden CR, Gillespie JR, James KA, Hirvi ER, Zaidi D, Wagner GF 2005 Nuclear targeting of stanniocalcin to mammary gland alveolar cells during pregnancy and lactation. Am J Physiol Endocrinol Metab 289:E634-E642
40. 2+ influx in freshwater trout. Gen Comp Endocrinol 72:136-143
41. Kanellis J, Bick R, Garcia G, Truong L, Tsao CC, Etemadmoghadam D, Poindexter B, Feng L, Johnson RJ, Sheikh-Hamad D 2003 Stanniocalcin-1, an inhibitor of macrophage chemotaxis and chemokinesis. Am J Physiol Renal Physiol 286:F356-F362
42. Ito D, Walker JR, Thompson CS, Moroz I, Lin W, Veselits ML, Hakim AM, Fienberg AA, Thinakaran G 2004 Characterization of stanniocalcin 2, a novel target of the mammalian unfolded protein response with cytoprotective properties. Mol Cell Biol 24:9456-9469
43. Yeung HY, Lai KP, Chan HY, Mak NK, Wagner GF, Wong CK 2005 Hypoxia-inducible factor-1-mediated activation of stanniocalcin-1 in human cancer cells. Endocrinology 146:4951-4960
44. Westberg JA, Serlachius M, Lankila P, Penkowa M, Hidalgo J, Andersson LC 2007 Hypoxic preconditioning induces neuroprotective stanniocalcin-1 in brain via IL-6 signaling. Stroke 38:1025-1030
45. Lal A, Peters H, St Croix B, Haroon ZA, Dewhirst MW, Strausberg RL, Kaanders JH, van der Kogel AJ, Riggins GJ 2001 Transcriptional response to hypoxia in human tumors. J Natl Cancer Inst 93:1337-1343
46. Bouras T, Southey MC, Chang AC, Reddel RR, Willhite D, Glynne R, Henderson MA, Armes JE, Venter DJ 2002 Stanniocalcin 2 is an estrogen-responsive gene coexpressed with the estrogen receptor in human breast cancer. Cancer Res 62:1289-1295
47. Iwao K, Matoba R, Ueno N, Ando A, Miyoshi Y, Matsubara K, Noguchi S, Kato K 2002 Molecular classification of primary breast tumors possessing distinct prognostic properties. Hum Mol Genet 11:199-206
48. Nakagawa T, Martinez SR, Goto Y, Koyanagi K, Kitago M, Shingai T, Elashoff DA, Ye X, Singer FR, Giuliano AE, Hoon DS 2007 Detection of circulating tumor cells in early-stage breast cancer metastasis to axillary lymph nodes. Clin Cancer Res 13:4105-4110
49. Urruticoechea A, Aguilar H, Sole X, Capella G, Martin LA, Dowsett M, Germa-Lluch JR 2007 Pre-clinical validation of early molecular markers of sensitivity to aromatase inhibitors in a mouse model of postmenopausal hormone-sensitive breast cancer. Breast Cancer Res Treat 10.1007/s10549-007- 9676-7